Mutual of Omaha Cancer, Heart Attack & Stroke Insurance: What Medicare Agents Should Know

Mutual of Omaha Cancer, Heart Attack & Stroke Insurance: What Medicare Agents Should Know

October 19, 2026•9 min read

Guest post by Andrew Saul.

Mutual of Omaha's Cancer Insurance and Heart Attack/Stroke Insurance are lump-sum policies. They pay a one-time cash benefit when a covered diagnosis happens. They are not Medicare Supplements, and they do not pay doctors or hospitals.

This post covers what Mutual of Omaha publishes about the two policies, how they fit next to Medicare Advantage and Medigap, and what to verify by state before you quote. Every product fact comes from Mutual of Omaha's public materials, linked in each section.

Two different designs under one name

Mutual of Omaha's Cancer, Heart Attack & Stroke page shows two designs, and agents should keep them apart.

  • Benefits paid upon diagnosis. A lump sum on an eligible diagnosis, policy forms CP1, CP2 and CP4 or state equivalent. This is the design this post covers.

  • Benefits paid for treatment. Policy forms CL10 and CHS10 or state equivalent. The treatment benefits page says it pays 14 cash benefits during treatment, with issue ages 18 to 99.

Same carrier. Different product. Different claim experience. Know which one your client is looking at.

The lump-sum policies sit in the carrier's Critical Advantage portfolio, next to a Critical Illness policy. The Product and Underwriting Guide (form 459896_0325, producer use only) is the main source for everything below.

How the lump-sum benefit works

Per the diagnosis benefits page and the guide:

  • Benefit amounts: $10,000 to $100,000, in $1,000 increments.

  • Cancer policy: pays 100% of the benefit amount on an eligible diagnosis of internal cancer or malignant melanoma.

  • Heart Attack/Stroke policy: pays 100% for heart attack or stroke, and 25% for coronary artery bypass surgery or coronary angioplasty surgery. The 25% benefit is payable once per insured person during the life of the policy.

  • 30-day waiting period for cancer coverage, starting on the policy effective date.

  • One payout, then done. Once 100% of the benefit has been paid, the policy ends unless benefits continue under an attached rider.

  • Paid to the insured. The consumer brochure (459893_1024) says the payment is sent to the policyholder, not the health care provider, with no reduction of benefits at any age.

One wording difference is worth catching. The brochure describes the 25% benefit as "first-ever" coronary artery disease and angioplasty. The guide describes it as bypass or angioplasty surgery, payable once per insured person. My advice: read the definitions in the client's state policy before you explain the 25% benefit.

Ages, terms and riders for Medicare-age clients

This is where the product narrows for a Medicare book. From the guide:

  • Cancer and Heart Attack/Stroke: issue ages 18 to 89 for lifetime coverage, but only 18 to 54 for term coverage (10, 15, 20 or 30 years). A 65-year-old is buying lifetime coverage.

  • Critical Illness: issue ages 18 to 64 lifetime. That puts it out of reach for most clients who are already on Medicare.

  • Cancer rider (on the Heart Attack/Stroke policy) and Heart Attack/Stroke rider (on the Cancer policy): $10,000 to $100,000, issue ages 18 to 89.

  • Cash Value rider: issue ages 18 to 60 and lifetime coverage only, so it rarely fits a Medicare-age client.

  • Riders are available only at time of issue. The rider conversation happens once.

  • Guaranteed renewable for life or until the end of the term period.

For a typical 65-plus client, the real menu is two policies, each with the other as a rider.

Who can be covered

The guide offers Individual, Individual plus child(ren) and Family plans. A few details matter for couples:

  • Premiums are unisex and based on the age of the oldest insured. Issue age is the applicant's age on the date the application is signed.

  • Either partner on a family plan may be the primary insured.

  • Partner continuation. If the primary insured's policy ends for reasons other than cancellation, nonpayment, end of a term or a cancer diagnosis in the 30-day probationary period, the covered partner can continue as primary by notifying the carrier in writing within 60 days.

  • The $100,000 cap counts everything. A person can own more than one Critical Advantage policy as long as coverage for any one condition does not exceed $100,000 across all Mutual of Omaha coverages, current or new.

If the client already has Mutual of Omaha lump-sum coverage, such as the Lump Sum Cancer rider in our Mutual of Omaha Hospital Protection post, ask first. The guide says accumulated lump-sum amounts above $50,000 with Mutual of Omaha bring extra underwriting.

Underwriting: knock-out questions, not rate classes

The guide lists two paths:

  • Express, $10,000 to $50,000: yes or no knock-out questions only.

  • Simplified, $51,000 to $100,000: knock-out questions plus MIB and pharmaceutical inquiry, and random telephone interviews.

The outcome is issue standard or decline. Anyone who answers "Yes" to a health question is excluded.

The uninsurable conditions differ by policy. For the cancer plans, the guide lists any HIV, AIDS or ARC diagnosis or treatment, internal cancer, malignant tumors, lymphoma, leukemia or melanoma within the last 10 years, and pending, abnormal or inconclusive tests within three years where cancer has not been ruled out.

For Heart Attack/Stroke, the list includes any disease, disorder or abnormality of the heart or blood vessels within 10 years, except high blood pressure or cholesterol considered controlled by a medical professional. It also includes certain diabetes histories (Type 1, Type 2 diagnosed under age 30, A1C greater than 7.0 within 12 months, or with tobacco use), pending heart tests within three years, and a build chart for the insured and partner.

The guide also prints a 12-month pre-existing condition definition and limitation. It appears as a footnote without saying which coverage it attaches to, so confirm it in the state policy.

A client excluded from Heart Attack/Stroke coverage may still qualify for the Cancer policy, which has its own question set.

State differences that change the answer

The guide's State Difference Matrix runs three pages. Several rows matter for Medicare clients:

  • Not available: Montana and New Mexico.

  • Maximum issue age 64 for all products: California and Massachusetts.

  • No coverage if covered by Medicaid: Arkansas, Connecticut, Delaware, Idaho, Maine, Utah, Virginia and West Virginia. Check this before you talk to a dual-eligible client.

  • Must have health insurance in force: California, Georgia, Massachusetts, Minnesota, New Jersey, New York and Vermont.

  • Product limits: the District of Columbia is cancer product only. New Jersey has no Heart Attack/Stroke coverage or rider. Virginia has no Cancer or Heart Attack/Stroke riders. New York does not cover coronary angioplasty under Heart Attack/Stroke and allows only one cancer policy at a time.

  • Longer health question lookbacks: Indiana (5 years for heart attack and stroke), Maryland (7 years), New Jersey, Pennsylvania and Utah (5 years), and Virginia (ever).

Benefits, riders and availability vary by state. Pull the state-specific brochure, outline of coverage and application before you quote.

Mapping the cash to Medicare's real gaps

A lump sum does not coordinate with Medicare. The useful question is how big the gap is.

Medicare Advantage. For 2027, CMS caps the in-network maximum out-of-pocket at $9,850, per the CY 2027 Part C bid review memo. That is the federal ceiling, not the client's number. Read the plan's actual MOOP in the Evidence of Coverage.

Original Medicare. Medicare.gov's chemotherapy page says that after the Part B deductible, the client typically pays 20% of the Medicare-approved amount for outpatient chemotherapy. Medicare.gov's coverage comparison adds that Original Medicare has no yearly out-of-pocket limit unless the client has Medigap or other coverage.

Medigap. Most plans cover the Part B coinsurance. The Medigap comparison chart shows Plan K pays 50% and Plan L pays 75%, with 2026 out-of-pocket limits of $8,000 and $4,000.

Here is the napkin math, as a hypothetical. An MA client's EOC shows a $6,000 in-network MOOP. A covered cancer diagnosis arrives after the waiting period. A $10,000 Cancer policy pays $10,000 once. That covers the full MOOP for the year with $4,000 left for travel, lost income or a spouse missing work.

For a Plan G client, the medical bills are mostly handled. The cash is for everything around them.

What it does not do

Say these limits early:

  • Not a Medicare Supplement and not a substitute for Medicare Advantage or Original Medicare.

  • Pays only for covered conditions. The guide says coverage is not provided for other diseases or accidents.

  • Exclusions apply and vary by state. The consumer page lists them, including armed forces service, intentionally self-inflicted injury, felonies, intoxication and non-prescribed controlled substances.

Process and compliance basics

The guide says rate sheets are not available, so quotes come from the e-App, WinFlex or the carrier's mobile quote app. Use the client's resident-state application. Power of attorney is not allowed, and monthly direct billing is not available. The guide is marked for producer use only, so show clients the approved consumer materials for their state.

If you raise these policies during a Medicare Advantage or Part D appointment, scope matters. Under 42 CFR 422.2264, a marketing appointment may not cover health care related products beyond the scope the beneficiary agreed to. Get a separate Scope of Appointment and document it. Never present a lump-sum policy as a Medicare plan.

What to verify before you quote

  • State availability, Medicaid status and the health-insurance-in-force rule.

  • Issue age limits, including the age 64 cap in California and Massachusetts.

  • Policy forms, riders and covered condition definitions for that state, especially the 25% benefit.

  • Health questions and lookbacks on the state application, plus the build chart.

  • Existing Mutual of Omaha lump-sum coverage against the $100,000 cap.

  • The client's EOC or Medigap plan letter to size the benefit.

FAQ

Is Mutual of Omaha Cancer Insurance a Medicare Supplement?

No. The carrier calls it a limited health benefit policy. It is a lump-sum policy that pays the insured on an eligible diagnosis. It does not pay Medicare cost sharing directly and is not Medigap.

Is there a waiting period?

Yes for cancer. A 30-day waiting period begins on the policy effective date. The guide also prints a 12-month pre-existing condition limitation, so confirm how it applies in the state policy.

Can a client with Medicaid buy it?

Not in every state. The guide's matrix says no coverage is available if the applicant is covered by Medicaid in Arkansas, Connecticut, Delaware, Idaho, Maine, Utah, Virginia and West Virginia. Check the state application.

What happens after a claim is paid?

Once 100% of the benefit is paid, the policy ends unless benefits continue under an attached rider. The 25% bypass or angioplasty benefit is payable once per insured person.

The Bottom Line

A lump-sum cancer policy is not a medical plan. It is a check with rules.

Know which design you are quoting. Know the state matrix. Pick riders at application. Size the cash to the client's real MOOP or Medigap gap.

For how this fits the rest of your ancillary lineup, read our ancillary insurance guide for Medicare clients. If you want help building a compliant ancillary conversation alongside your Medicare book, book a call with Brock or join one of our weekly agent webinars.

Product details are from Mutual of Omaha's Product and Underwriting Guide (459896_0325), brochure (459893_1024) and public product pages, reviewed October 19, 2026. Benefits, availability and terms vary by state. Always confirm in current carrier materials.

Andrew Saul

Andrew Saul

Andrew joined Brock in October of 2026. His role centers on distribution strategy, agent development, strategic partnerships and building scalable growth across the health, life, annuity and retirement markets. He brings more than a decade of experience in Medicare, life and annuity sales, distribution, training and leadership, with a particular focus on helping agents understand the economic, regulatory and strategic forces shaping our industry.

Back to Blog